Cash grants
Explore cash grants for companies and research teams. This directory lists non-dilutive funding paid out as a grant, from government innovation agencies, research councils, foundations and corporate programs, for research, product development and scale-up, with the deadline, award size and eligibility on every listing.
Showing 961-984 of 4,984 grants
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21)
NIH · United States
Funds the exploratory version of the same work on screening tests and treatments for serious newborn conditions.
Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases
🇺🇸NIH · United States
Funds basic biochemical or biological work on a protein from a published list — druggable, linked to a rare disease, and barely studied.
Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of NIDDK
🇺🇸NIH · United States
Funds pilot basic and translational work on HIV complications in the organs and processes the diabetes, digestive and kidney institute covers.
Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids
🇺🇸NIH · United States
Funds basic research on the harm caused by a single exposure to ultra-potent synthetic opioids, including the effects that appear later.
EIC Pre-accelerator - Widening
🇧🇬European Commission · European Union
Funds deep-tech start-ups in EU widening countries with up to EUR 500,000 to reach investment readiness and qualify for EIC Accelerator or other funding.
ARO Core BAA — Single Investigator
🇺🇸ARO · United States
Offers core basic research grants across physical, engineering, and information science domains in the Army.
MSCA Doctoral Networks 2027
🇪🇺European Commission · European Union
Funds partnerships of universities, research institutes and businesses to jointly run doctoral training programmes for early-career researchers.
Accelerating the Pace of Substance Use Research Using Existing Data (R01)
NIH · United States
Funds new analysis of existing social, behavioral, administrative and neuroimaging data on drug use, prevention, and related health services.
Accelerating the Pace of Substance Use Research Using Existing Data (R21)
NIH · United States
Funds the exploratory R21 version of new analysis on existing social, behavioral, administrative and neuroimaging drug-use data.
Catalyze Product Definition Medical Device prototype design/testing and disease target identification and assay development
🇺🇸NIH · United States
Funds building and testing an early medical-device prototype and its matching disease target or assay, for heart, lung, blood or sleep disease.
Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research
🇺🇸NIH · United States
Funds rigorously validating a transformative, multi-use platform or technology aimed at heart, lung, blood or sleep disease.
Catalyze: Product Definition Medical Device Prototype Optimization
🇺🇸NIH · United States
Funds refining a medical-device prototype's design, assays and research tools for heart, lung, blood or sleep disease.
Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification
🇺🇸NIH · United States
Funds identifying and validating a disease target, then finding a preliminary drug, biologic or combination-product lead against it.
Catalyze: Product Definition for Small Molecules, Biologics, and Combination Products - Preliminary Product/Lead Series Identification and Combination Product Prototype
🇺🇸NIH · United States
Funds turning a preliminary drug, biologic or combination-product lead into a combination-product prototype for heart, lung, blood or sleep disease.
A+ Early-Stage Startup Grant Program
🇹🇼ITRI · Taiwan
Funds Taiwan early-stage technology startups moving from functional prototype to MVP validation and market landing.
Stimulating Hematology Investigation: New Endeavors (SHINE)
🇺🇸NIH · United States
Funds basic and early translational research on non-cancerous blood disorders, in topics three institutes refresh every year.
Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions
🇺🇸NIH · United States
Funds a small research project at a college that teaches undergraduates and receives little NIH money, with students doing the research.
Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions
🇺🇸NIH · United States
Funds a small research project at a college that teaches undergraduates and receives little NIH money, with students doing the research.
Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment
NIH · United States
Funds academic-industry partnerships that turn a lab discovery into a working diagnostic or treatment tool, without a clinical trial attached.
Advancing Healthcare for Older Adults from Populations that Experience Health Disparities
🇺🇸NIH · United States
Funds research into screening, decision-making and care coordination for older adults in populations that get worse healthcare.
Basic Research in Cancer Health Disparities (R01)
NIH · United States
Funds basic mechanistic research into the biological and genetic causes of cancer health disparities — and into building the tools that research needs.
Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies
NIH · United States
Funds mechanistic work on the lasting harms cancer therapy causes, and on turning that understanding into ways to prevent them.
Development of Animal Models and Related Biological Materials for Research
🇺🇸NIH · United States
Funds developing or improving animal models and related materials — but only where they serve several institutes and several body systems.
Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders
🇺🇸NIH · United States
Funds the discovery and first evaluation of biomarkers for neurological and neuromuscular disorders, ending with candidates ready for formal validation.